SEC2-induced superantigen and antitumor activity is regulated through calcineurin

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Superantigens (SAgs) trigger potent immune responses by forming a ternary complex with T-cell receptors (TCRs) and MHC class II molecules.
• The precise intracellular signaling events underlying SAg-mediated immune activation remain incompletely understood.

Purpose of the Study:

• To elucidate the role of the Ca(2+)/calcineurin (CaN)/nuclear factor of activated T cells (NFAT) signaling pathway in SEC2 SAg-induced T-cell activation.
• To evaluate the impact of an engineered SEC2 mutant, SAM-1, on T-cell stimulation, cytokine production, cytotoxicity, and in vivo antitumor activity.

Main Methods:

• Investigated the Ca(2+)/CaN/NFAT pathway in SEC2-induced T-cell activation.
• Utilized cyclosporine A (CsA), a calcineurin inhibitor, to assess pathway involvement.
• Selected and characterized an engineered SEC2 mutant (SAM-1) through biological activity assays.
• Quantified CaN activity and gene transcription of NFAT substrates.
• Assessed cytokine production, cytotoxicity, and in vivo antitumor efficacy of SAM-1.

Main Results:

• The Ca(2+)/CaN/NFAT signaling pathway is critical for SEC2-induced T-cell activation.
• Cyclosporine A completely inhibited SEC2's T-cell stimulating capacity.
• SAM-1 demonstrated enhanced T-cell stimulating potency, cytokine production, and cytotoxicity compared to SEC2.
• CaN activity and NFAT target gene transcription correlated directly with SAM-1-induced T-cell activation.
• SAM-1 exhibited improved in vivo antitumor activity.

Conclusions:

• The Ca(2+)/CaN/NFAT pathway is a key mediator of SAg-driven immune responses.
• The engineered mutant SAM-1 potentiates T-cell activation through intensified Ca(2+)/CaN/NFAT signaling.
• SAM-1 holds promise for enhanced immunotherapy due to its improved antitumor efficacy.